secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001809519-25-000088
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx stockholders elect three Class II directors and ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Elected Christopher Adams, Trevor Bezdek, and Scott Wagner as Class II directors; each received >2.6B votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY 2025; 99.9% voted for (2.66B for).
- Advisory say-on-pay approved with 2.62B votes for (99.9% of votes cast excluding abstentions).
- Total voting power at meeting represented ~99.5% of outstanding shares; Class B shares hold 10 votes each.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000088/0001809519-25-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951925000088/gdrx-20250603.htm
  HTML page:      https://secwatch.observer/filing/0001809519-25-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer